The global brain implants market size was valued at USD 6.43 billion in 2024 and is expected to reach USD 14.05 billion by 2032, at a CAGR of 10.27% during the forecast period

The market growth is largely fueled by the rising prevalence of neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, and depression, alongside technological advancements in brain-computer interfaces (BCIs) and deep brain stimulation (DBS) devices, enhancing treatment outcomes in both clinical and research settings

Furthermore, the aging population and increasing consumer demand for effective, minimally invasive, and technologically advanced neurological solutions are establishing brain implants as a key intervention for managing complex neurological conditions. These converging factors are accelerating the adoption of brain implant solutions, thereby significantly boosting the industry's growth